Payer & Market Access Expert, Gross-to-Net & Formulary Strategy
- Compenso: da 175 USD a 200 USD / ora
- Contratto: Part time
- Chi può candidarsi: Stati Uniti
- Pubblicata il 5 ago 2026
In breve
This remote role involves creating and critiquing evaluation rubrics for commercial drugs and drug development programs, with a focus on gross to net and formulary strategy assumptions. Candidates must have five plus years of experience in market access, pricing and reimbursement, or managed markets.
Descrizione
Descrizione in inglese, così come pubblicata da Mercor.
Mercor is partnering with a biotech and pharma research team on expert human-evaluation work, creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a payer / market access expert for a paid pilot, with the potential to continue as the work scales.
Responsibilities
-
Create and critique rubrics that analyze commercial drugs and drug-development programs
-
Set and pressure-test gross-to-net and formulary-tier assumptions by drug class
-
Judge whether coverage, rebating, and tiering assumptions reflect how payers actually behave
-
Apply this across the pilot's set of drugs and drug classes
Requirements
-
US-based payer / market access professional
-
Familiarity with biotech/pharma development programs
-
Hands-on with gross-to-net, rebates, and formulary tiering by drug class
-
5+ years in market access, pricing & reimbursement, or managed markets
Engagement Details
-
Duration: Approximately 10, 20 hours over a 1, 2 week pilot
-
Remote, US-based
Why Participate
-
Help improve expert AI evaluation of drugs and drug-development programs
-
Recurring engagement for strong contributors